Skip to main content
Log in

Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery

  • Clinical Research
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Background

While bariatric surgery has proved highly successful at producing sustained weight loss, variability in treatment response persists. A better understanding of the pathophysiology of appetite and obesity may improve patient selection and management. Research into feeding behavior and satiety has focused on the role of dopamine in reward-based behaviors. Specifically, positron-emission computed tomography (PET) has demonstrated reduced brain dopamine receptor availability in obese subjects compared to controls. This may be due to a primary deficiency in dopamine receptors or to secondary dopamine receptor downregulation. We performed a preliminary study to investigate dopamine D2 receptor activity in obese subjects before and after laparoscopic Roux-en Y gastric bypass (LGBP).

Methods

Five female subjects, ages 20 to 38 years old with a mean body mass index of 45, underwent PET with [C-11] raclopride injection. Five regions of interest were studied: ventral striatum, anterior and posterior putamen, and anterior and posterior caudate nucleus. Repeat PET was performed at 6 weeks following LGBP. D2 receptor binding was compared within subjects pre- and post-surgery. Baseline D2 binding was also compared to historical nonobese controls.

Results

D2 receptor availability increased 6 weeks after gastric bypass surgery. The increase in receptor availability appeared roughly proportional to the amount of weight lost. No significant difference in D2 binding was seen between the obese subjects and historical nonobese controls.

Conclusions

Brain available dopamine D2 binding appears to increase following GBP. This preliminary finding needs to be replicated in a larger population but suggests that diminished D2 binding in the obese may be due to D2 receptor downregulation. Changes in available dopamine receptor binding may play an important role in centrally mediated appetite suppression and resultant weight loss after LGBP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Chau DT, Roth RM, Green AI. The neural circuitry of reward and its relevance to psychiatric disorders. Curr Psychiatry Rep. 2004;6:391–9.

    Article  PubMed  Google Scholar 

  2. Volkow N, Wang G, Fowler J, et al. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci. 2008;363:3191–200. doi:10.1098/rstb.2008.0107.

    Article  PubMed  Google Scholar 

  3. Comings DE, Blum K. Reward deficiency syndrome: genetic aspects of behavioral disorders. Prog Brain Res. 2000;126:325–41.

    Article  CAS  PubMed  Google Scholar 

  4. Volkow ND, Fowler JS, Wang GJ, et al. Imaging dopamine's role in drug abuse and addiction. Neuropharmacology. 2009;1:3–8. doi:10.1016/j.neuropharm.2008.05.022.

    Article  Google Scholar 

  5. Bina KG, Cincotta AH. Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice. Neuroendocrinology. 2000;71:68–78.

    Article  CAS  PubMed  Google Scholar 

  6. Klein TA, Neumann J, Reuter M, et al. Genetically determined differences in learning from errors. Science. 2007;318:1642–5.

    Article  CAS  PubMed  Google Scholar 

  7. Pijl H. Reduced dopaminergic tone in hypothalamic neural circuits: expression of a “thrifty” genotype underlying the metabolic syndrome? Eur J Pharmacol. 2003;480:125–31.

    Article  CAS  PubMed  Google Scholar 

  8. Volkow ND, Wang GJ, Telang F, et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage. 2008;42:1537–43. doi:10.1061/j.neuroimage.2008.06.002.

    Article  PubMed  Google Scholar 

  9. Wang GJ, Volkow ND, Logan J, et al. Brain dopamine and obesity. Lancet. 2001;3:354–7.

    Article  Google Scholar 

  10. Beck AT, Steer RA. Brown: beck depression inventory-II manual. San Antonio: Psychological Corporation; 1996.

    Google Scholar 

  11. Collignon A, Maes F, Delaere D, et al. Automated multi-modality image registration based on information theory. In: Bizais Y, Barillot C, DiPaola R, editors. Information processing in medical imaging. Dordrecht: Kluwer Academic Publishers; 1995. p. 263–74.

    Google Scholar 

  12. Friston KJ, Penny W, Phillips C, et al. Classical and Bayesian inference in neuroimaging: theory. Neuroimage. 2002;16:465–83.

    Article  CAS  PubMed  Google Scholar 

  13. Wong DF. In vivo imaging of D2 dopamine receptors in schizophrenia: the ups and downs of neuroimaging research. Arch Gen Psychiatry. 2002;59:31–4.

    Article  CAS  PubMed  Google Scholar 

  14. Lammertsma AA, Hume SP. Simplified reference tissue model for PET receptor studies. Neuroimage. 1996;4:153–8.

    Article  CAS  PubMed  Google Scholar 

  15. Breier A, Su TP, Saunders R, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA. 1997;94:2569–74.

    Article  CAS  PubMed  Google Scholar 

  16. Zhou Y, Endres CJ, Brasic JR, et al. Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model. Neuroimage. 2003;18:975–89.

    Article  PubMed  Google Scholar 

  17. Volkow N, Wise R. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555–60.

    Article  CAS  PubMed  Google Scholar 

  18. Munro CA, McCaul ME, Oswald LM, et al. Striatal dopamine release and family history of alcoholism. Alcohol Clin Exp Res. 2006;30(7):1143–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank The Association of Women Surgeons Foundation and Ethicon Endo-Surgery for their grant support in this pilot project.

We also acknowledge other grant support from Dr. Dean Wong's Lab: R01MH078175, R01AA12839, and DA00412 and the lab support from Jeffrey Galeki (Sr. Research Assistant) and Cynthia Hawes.

Disclosures

This study was funded by a grant from the Association of Women Surgeons and Ethicon Endo-Surgery. The authors have no other commercial associations that might be a conflict of interest in relation to this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kimberley E. Steele.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Steele, K.E., Prokopowicz, G.P., Schweitzer, M.A. et al. Alterations of Central Dopamine Receptors Before and After Gastric Bypass Surgery. OBES SURG 20, 369–374 (2010). https://doi.org/10.1007/s11695-009-0015-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-009-0015-4

Keywords

Navigation